Olaparib Gains BRCA-Mutated Prostate Cancer Indication ...Middle East

Medscape - News
The new indication adds to the PARP inhibitor's previous approvals for HRR-mutated metastatic castration-resistant prostate cancer as well as for ovarian, breast, and pancreatic cancer indications. Medscape Medical News

Hence then, the article about olaparib gains brca mutated prostate cancer indication was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Olaparib Gains BRCA-Mutated Prostate Cancer Indication )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News